238 A Novel Algorithm for Peyronie's Management At the Time of Penile Prosthesis to Maximize Length Without Elevation of the Neurovascular Bundle. Issue 1 (1st April 2022)

• Record Type: Journal Article
• Authors: Balzano, F; Miran, A; Warner, J
• Is Part Of: Journal of sexual medicine. Volume 19:Issue 1(2022)Supplement
• Page Start: S119
• Page End: S119
• Publication Date: 2022-04-01
• Subjects: Sexual disorders -- Periodicals; Sex -- Periodicals; Sexual health -- Periodicals; 616.69005
• DOI: 10.1016/j.jsxm.2022.01.252
• Languages: English
• ISSNs: 1743-6095

Abstract

ABSTRACT: Introduction: Peyronie's disease (PD) is a fibrous transformation of the tunica albuginea within the corpora cavernosa causing curvature of the penis while erect. This can not only be painful but can also cause narrowing, shortening, an hourglass deformity and problems with penetrative intercourse. Objective: There are many means of management of Peyronie's disease at the time of penile implant. Modelling is a commonly used approach but leaves the penis without increased length. Multi-incisional techniques enhance length restoration, but risk significant vascular and neurologic compromise. Herein, we present our experience with a novel algorithm to approach Peyronie's disease with an effort to enhance and restore length without elevation of the neurovascular bundle. Methods: A retrospective review was performed of an institutional review board approved database. Patients treated for Peyronie's disease and erectile dysfunction with penile implant from 8/16/18 to 8/20/2020 were evaluated. Results: In our cohort of 33 patients there is an average of 1.9 cm average stretch difference in stretch penile length. There was a 2.15 cm difference in the cohort subset that utilized the Brock technique. We had no loss of sensation or glans ischemia. There was one patient with autoinflation. All patient had less than 10 degrees of residual curvature. Conclusions: In conclusion with the proposed algorithm we are able to safely maximize length restoration without elevation of the neurovascular bundle. We do require more patients with longer follow-up however to ensure the safety of this algorithm. Disclosure: Any of the authors act as a consultant, employee or shareholder of an industry for: Coloplast, Boston Scientific, Olympus